rs111033367
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PP1_ModeratePM2PVS1PP4PM3
This summary comes from the ClinGen Evidence Repository: The allele frequency of the p.Cys1447GlnfsX29 variant in the USH2A gene is 0.0009% (1/111250) of European (Non-Finnish) chromosomes by the Genome Aggregation Database (http://gnomad.broadinstitute.org), which is a low enough frequency to award PM2 based on the thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive hearing loss (PM2). The p.Cys1447GlnfsX29 variant is predicted to cause a premature stop codon in biologically-relevant-exon 20 of 72 that leads to an absent protein in a gene in which loss-of-function is an established mechanism (PVS1). This variant has been detected as compound heterozygous with p.Cys759Phe or p.Glu767SerfsX21 in six Usher syndrome probands, and as homozygous in eight Usher syndrome probands (PM3_VeryStrong; PMID:9624053, 15325563, 18641288, 18665195, 20440071). The p.Cys1447GlnfsX29 variant in USH2A has been reported to segregate with hearing loss in at least 2 family members (PP1_Moderate; PMID:20440071, 9624053). At least one patient with a variant in this gene displayed features of mild to severe hearing loss and retinitis pigmentosa (PP4; PMID:9624053, 15325563, 18641288, 18665195, 20440071). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Usher syndrome based on the ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: PM2, PVS1, PM3_VeryStrong, PP1_Moderate, PP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA252228/MONDO:0019501/005
Frequency
Consequence
ENST00000307340.8 frameshift
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 2Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 2AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- retinitis pigmentosa 39Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000307340.8. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| USH2A | NM_206933.4 | MANE Select | c.4338_4339delCT | p.Cys1447GlnfsTer29 | frameshift | Exon 20 of 72 | NP_996816.3 | ||
| USH2A | NM_007123.6 | c.4338_4339delCT | p.Cys1447GlnfsTer29 | frameshift | Exon 20 of 21 | NP_009054.6 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| USH2A | ENST00000307340.8 | TSL:1 MANE Select | c.4338_4339delCT | p.Cys1447GlnfsTer29 | frameshift | Exon 20 of 72 | ENSP00000305941.3 | ||
| USH2A | ENST00000366942.3 | TSL:1 | c.4338_4339delCT | p.Cys1447GlnfsTer29 | frameshift | Exon 20 of 21 | ENSP00000355909.3 | ||
| USH2A | ENST00000674083.1 | c.4338_4339delCT | p.Cys1447GlnfsTer29 | frameshift | Exon 20 of 73 | ENSP00000501296.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151840Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000399 AC: 1AN: 250692 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1460590Hom.: 0 AF XY: 0.0000193 AC XY: 14AN XY: 726642 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151840Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74138 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
ClinVar submissions as Germline
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at